EODData

MEMBERSHIP REGISTER LOG IN

FRA, UR8: UroGen Pharma Ltd

21 May 2026
LAST:

25.36

CHANGE:
 1.59		OPEN:
25.36		HIGH:
25.36		ASK:
0.00		VOLUME:
0
CHG(%):
6.69		PREV:
23.77		LOW:
25.36		BID:
0.00		 

CHART

RECENT END OF DAY PRICES

DateOpenHighLowCloseVolume
21 May 2625.3625.3625.3625.360
20 May 2623.7723.7723.7723.770
19 May 2623.9223.9223.9223.920
18 May 2623.9823.9823.9823.980
15 May 2624.8224.8224.8224.820
14 May 2625.8625.8625.8625.860
13 May 2624.7925.4824.7925.4865
12 May 2625.9925.9925.9925.990
11 May 2624.3624.3624.3624.360
08 May 2622.1325.6622.1325.20303

PROFILE

Name:UroGen Pharma Ltd
About:UroGen Pharma Ltd. engages in the development and commercialization of solutions for urothelial and specialty cancers. It offers RTGel, a novel proprietary polymeric biocompatible, reverse thermal gelation hydrogel technology; and Jelmyto for pyelocalyceal solution. The company's lead product candidate are UGN-102 for pyelocalyceal solution; UGN-103, which is in phase 3 of clinical trial for intravesical solution; and UGN-104 that is in phase 3 of clinical trial for pyelocalyceal solution designed for the treatment of several forms of non-muscle invasive urothelial cancer that include low-grade upper tract urothelial cancer and low-grade intermediate risk non-muscle invasive bladder cancer (NMIBC). It is also developing UGN-301, UGN-301+ UGN 201, and UGN-301+gemcitabine that are in phase 1 of clinical trial for the treatment of high-grade NMIBC. The company has license agreement with Agenus Inc. to develop, make, use, sell, import, and commercialize products of Agenus for the treatment of cancers of the urinary tract via intravesical delivery; and licensing and supply agreement with medac Gesellschaft für klinische Spezialpräparate m.b.H. to develop UGN-103 and UGN-104. UroGen Pharma Ltd. was incorporated in 2004 and is based in Princeton, New Jersey.
Sector:Healthcare
Industry:Biotechnology
Address:400 Alexander Park Drive, Princeton, NJ, United States, 08540
Website:https://www.urogen.com
ISIN:IL0011407140

API SERVICE  NEW

Have you tried our new API Service yet?

For more information, visit our API page.

You can get your ApiKey over HERE.

If you're ready to get going, then jump over to:
https://api.eoddata.com

SYMBOL HISTORY

   Add to Watchlist

DOWNLOAD DATA

Download stock quote history quickly and easily in a variety of formats to suit your needs.

  Download

FUNDAMENTALS

Trailing P/E:-6.62 
Forward P/E:-5.34 
PEG Ratio:-0.26 
Price to Sales:9.83 
Price to Book:-8.16 
Profit Margin:-1.71 
Operating Margin:-1.00 
Return on Assets:-0.34 
Return on Equity:14.41 
Revenue:81.99M 
Shares:46.26M 
Market Cap:1.173B 

TECHNICAL INDICATORS

MA5:24.374.1%
MA10:24.872.0%
MA20:22.4712.9%
MA50:18.7635.2%
MA100:18.1439.8%
MA200:17.6243.9%
STO9:71.62
STO14:90.80 
RSI14:68.48 
WPR14:-9.20 
MTM14:5.98
ROC14:0.31 
ATR:1.09 
Week High:25.862.0%
Week Low:23.776.7%
Month High:25.992.5%
Month Low:19.1543.9%
Year High:25.992.5%
Year Low:3.30667.6%